The Four Keys to Achieving Your Financial Goals

Marc Lichtenfeld
by Marc Lichtenfeld, Chief Income Strategist, The Oxford Club

Despite the fact that the S&P 500 has doubled since the financial crisis in 2009, a shocking number of people still seem turned off by the stock market.

According to a poll conducted by Prudential, 58% of respondents “have lost faith” in the stock market. Even more stunning, 44% say they will NEVER invest in the stock market again. Never ever!

What that tells me is there’s still a lot of buying power on the sidelines. Call me a cynic, but people often say one thing and do another.

I’m sure there are some investors who got so burned by the collapse in 2008 and 2009, that they really never will put another penny into the market. They’ll cower in fear, with all of their money in gold or bury their cash under the floorboards. And while that might keep their money secure, it’ll never produce wealth.

If you’re a long-time reader of the site or subscribe to Investment U Daily, you know that we don’t try to time the markets. That’s a fool’s game. Sure, a market timer might make a great call now and then, but I don’t know any who are consistently accurate.

So rather than the futile exercise of trying to figure out the exact moment to buy or sell stocks, stick to our “Four Pillars of Wealth” to achieve your financial goals. The results will be better and you’ll be able to sleep at night.

  1. Stick to an Asset Allocation ModelInvestment U follows a formula that won Dr. Harold Markowitz the Nobel Prize in finance in 1990.
  2. Adhere to Safety Switch – Buying a stock is easy. Knowing when to sell is the hard part. This way we let our winners ride and cut our losses before they get too big.
  3. Understand Position Sizing – Invest no more than four percent of your portfolio in any one stock. That way if things go wrong, no one particular holding will sink your entire portfolio.
  4. Cut your Expenses (Including Taxes) – Invest in no load funds with low expense ratios like Vanguard index funds. Also, choose closed-end funds that trade at a discount instead of open-end mutual funds with up-front fees or loads.

You can potentially lower your taxes by not selling your gains for one year, so that they qualify for the long-term capital gains tax rate (rather than the higher short term), avoid actively managed funds in your taxable accounts and keep your high-yield investments in your IRAs or other tax-deferred accounts.

The markets are a little tough right now. The big financials, such as Morgan Stanley (NYSE: MS), were just got downgraded by Moody’s. Typically, it’s difficult for the markets to rally without the help of the financials.

Several other sectors such as networking, transportation and utilities are also weak. One that still looks strong is the drug and biotech sector.

The point is there’s still stocks out there performing well. You just have to look harder for them.

Consider following the Four Pillars of Wealth to achieve your financial goals and leave the panicking to those who have ridiculously sworn off the markets forever.

Good Investing,

Marc Lichtenfeld

Editor’s Note: These “Four Pillars of Wealth” were originally developed by Alexander Green for The Oxford Club. Marc and Alex wanted me to share a more detailed outline of these wealth preservation tips for those interested in learning more.

For a free copy of The Oxford Club’s full report on “The Four Pillars of Wealth,” click here.

comments powered by Disqus

Playing the Strength in Biotech

As Marc wrote today, biotech has been one of the few strong points in the markets this year.

For instance, the iShares Nasdaq Biotech Index (Nasdaq: IBB) is up about 20% for the year while the SPDR S&P 500 Index (NYSE: SPY) has gained under 5% in the same timeframe.

And Marc has been banging the table on biotech and healthcare stocks for some time now. That’s why he started his FirstLine Investor Alert service back in January.

And Marc wanted to share one of his recent, successful picks with our Plus subscribers because he thinks the company is still in the early stages of an incredible growth trend.

The company is Genomic Health (Nasdaq: GHDX) and Marc has bagged a solid 18.7% gain for his FirstLine subscribers since he recommended it in February.

Here’s why he thinks the company is poised to keep running for the foreseeable future:

“Genomics and DNA sequencing are at the very early stages of a boom. Right now, we have the ability to extract an incredible amount of information from human DNA, yet we don’t necessarily know what to do with it all.

“Genomic Health puts some of that information to work. Its Oncotype DX test reads the DNA of breast cancer and Stage 2 colon cancer tumors to determine whether chemotherapy will work against the disease and the likelihood of recurrence.

“This knowledge allows patients to get the proper treatment faster, without wasting their time on ineffective therapies that make them even sicker.

“Oncotype DX is already considered standard of care for early stage breast cancer and is covered by most insurance plans.

“Genomic Health isn’t a tiny start up hoping to land a lucrative deal or waiting for clinical data that will make or break the company. This is a real business with cash flow and profits that are projected to grow 48% per year over the next five years.”

Marc also wanted to share that he thinks that it’s a good sign that the stock is holding strength through June. According to him, biotech shares typically sell-off for about a month after the annual meeting of the American Society of Clinical Oncology (which was June 1 to 5).

In that case, you may want to hold out for a bit longer before possibly plunking for shares, but GHDX should definitely be on your watch list. It’s likely still in the early stages of a major trend.

– Justin Dove with Marc Lichtenfeld

Live Twitter Feed